Myriad Genetics Inc (NASDAQ:MYGN)

Delayed Data
As of Mar 30
 -0.81 / -3.47%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 20.00, with a high estimate of 27.00 and a low estimate of 13.00. The median estimate represents a -11.19% decrease from the last price of 22.52.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since March, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -58.33%
Growthannually -10.00%


Growthquarterly -3.52%
Growthannually 7.95%
Key to the earnings and sales forecast charts.